Literature DB >> 19892682

Acute pancreatitis and critical illness: a pancreatic tale of hypoperfusion and inflammation.

Sarah E Greer1, Kenneth W Burchard2.   

Abstract

Since it was first widely recognized at the end of the 19th century, acute pancreatitis has proven a formidable clinical challenge, frequently resulting in management within critical care settings. Because the early assessment of severity is difficult, the recognition of severe acute pancreatitis (SAP) and the implementation of critical care treatment precepts often are delayed. Although different management strategies for life-threatening features of SAP have been debated for decades, there has been little recent reduction in mortality rates, which can be as high as 30%. This article discusses severity designation at the time of diagnosis, reviews the pathophysiologic mechanisms so well characterized by the noxious combination of severe systemic inflammation and hypoperfusion, and provides a management algorithm that parallels current critical care strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19892682     DOI: 10.1378/chest.08-2616

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Acute pancreatitis: should we use antibiotics?

Authors:  Laura J Nicholson
Journal:  Curr Gastroenterol Rep       Date:  2011-08

2.  Early fluid resuscitation reduces morbidity among patients with acute pancreatitis.

Authors:  Matthew G Warndorf; Jane T Kurtzman; Michael J Bartel; Mougnyan Cox; Todd Mackenzie; Sarah Robinson; Paul R Burchard; Stuart R Gordon; Timothy B Gardner
Journal:  Clin Gastroenterol Hepatol       Date:  2011-04-08       Impact factor: 11.382

3.  Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats.

Authors:  Manar A Nader; Heba M Wagih
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

4.  Aggressive hydration with Lactated Ringer's solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled double-blind clinical trial.

Authors:  Alireza Shaygan-Nejad; Abdol Rahim Masjedizadeh; Ali Ghavidel; Morteza Ghojazadeh; Manouchehr Khoshbaten
Journal:  J Res Med Sci       Date:  2015-09       Impact factor: 1.852

5.  Comparison of Existing Clinical Scoring Systems in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients: A Retrospective Study.

Authors:  Lei Qiu; Rui Qing Sun; Rong Rong Jia; Xiu Ying Ma; Li Cheng; Mao Chun Tang; Yan Zhao
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

6.  Renoprotective activity of sivelestat in severe acute pancreatitis in rats.

Authors:  Houhong Wang; A-Mao Tang; Daren Liu; Guogang Li; Longyun Ye; Xiaowen Li; Chao Li; Li Chen
Journal:  Exp Ther Med       Date:  2013-04-24       Impact factor: 2.447

7.  Clinical study of critical patients with hemorrhagic fever with renal syndrome complicated by acute respiratory distress syndrome.

Authors:  Hong Du; Jing Li; Wei Jiang; Haitao Yu; Ye Zhang; Junning Wang; Pingzhong Wang; Xuefan Bai
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.